Literature DB >> 17158488

Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden.

Povl Munk-Jørgensen1, Christer Allgulander, Alv A Dahl, Leslie Foldager, Marthin Holm, Ib Rasmussen, Anti Virta, Marja-Terttu Huuhtanen, Hans-Ulrich Wittchen.   

Abstract

OBJECTIVES: This study assessed the prevalence rate of generalized anxiety disorder among patients of general practitioners in Denmark, Finland, Norway, and Sweden and determined whether general practitioners recognize the condition and its correlates.
METHODS: Data were gathered in September 2001. Participating patients received a questionnaire that included the Generalized Anxiety Questionnaire and the Depression Screening Questionnaire. The scale used DSM-IV criteria to identify generalized anxiety disorder and major depressive episode. General practitioners filled in a questionnaire about their patients' mental and physical illnesses, including generalized anxiety and major depressive episode. General practitioners' basic sociodemographic data and professional career information were also gathered.
RESULTS: A total of 648 general practitioners and 8,879 patients participated in the study. The age-standardized rates for generalized anxiety disorder ranged from 4.1 to 6.0 percent for males and from 3.7 to 7.1 percent for females; for major depressive episode the rates ranged from 7.2 to 11.5 percent for males and from 9.9 to 14.2 percent for females. The proportion of generalized anxiety disorder cases recognized by general practitioners varied from 33 percent in Denmark to 53 percent in Norway. Recognition of generalized anxiety disorder by general practitioners was associated with presentation of anxiety problems by the patients. Physical symptoms as a reason for a consultation was associated with lowered recognition of generalized anxiety disorder. Previous diagnoses of generalized anxiety disorder or anxiety neurosis were associated with increased recognition of generalized anxiety disorder.
CONCLUSIONS: Of the total percentage of cases of generalized anxiety disorder in general practice (4.8 percent for males and 6.0 percent for females), only one-third to one-half of the cases were identified by the general practitioners.

Entities:  

Mesh:

Year:  2006        PMID: 17158488     DOI: 10.1176/ps.2006.57.12.1738

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  28 in total

1.  Psychiatric caseness is a marker of major depressive episode in general practice.

Authors:  Søren Dinesen Ostergaard; Leslie Foldager; Christer Allgulander; Alv A Dahl; Marja-Terttu Huuhtanen; Ib Rasmussen; Povl Munk-Jørgensen
Journal:  Scand J Prim Health Care       Date:  2010-07-13       Impact factor: 2.581

2.  [Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].

Authors:  Antoni Sicras-Mainar; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez
Journal:  Aten Primaria       Date:  2009-02-03       Impact factor: 1.137

3.  Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors.

Authors:  Nader Haftgoli; Bernard Favrat; François Verdon; Paul Vaucher; Thomas Bischoff; Bernard Burnand; Lilli Herzig
Journal:  BMC Fam Pract       Date:  2010-09-15       Impact factor: 2.497

4.  The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care.

Authors:  E Asselmann; J Venz; L Pieper; H-U Wittchen; D Pittrow; K Beesdo-Baum
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-09       Impact factor: 6.892

Review 5.  Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

Authors:  Keming Gao; David V Sheehan; Joseph R Calabrese
Journal:  Expert Rev Neurother       Date:  2009-08       Impact factor: 4.618

6.  Predictions get tougher in older individuals: a longitudinal study of optimism, pessimism and depression.

Authors:  Diana Armbruster; Lars Pieper; Jens Klotsche; Jürgen Hoyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-09-09       Impact factor: 4.328

7.  Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample.

Authors:  Jude U Ohaeri; Abdel W Awadalla
Journal:  Med Sci Monit       Date:  2012-03

8.  Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot study.

Authors:  Kine Gregersen; Ragna A Lind; Jørgen Valeur; Tormod Bjørkkjær; Arnold Berstad; Gülen Arslan Lied
Journal:  Int J Gen Med       Date:  2010-12-06

9.  Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life.

Authors:  Robert Johansson; Per Carlbring; Åsa Heedman; Björn Paxling; Gerhard Andersson
Journal:  PeerJ       Date:  2013-07-09       Impact factor: 2.984

10.  Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study.

Authors:  Ariel Berger; John Edelsberg; Michael Treglia; Jose Ma J Alvir; Gerry Oster
Journal:  BMC Psychiatry       Date:  2012-10-23       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.